During PCE's recent Series 2 Live Stream conferences, attendees had the opportunity to ask Dr Samuel Louie—expert faculty for the asthma presentation—a variety of questions. This activity provides a compilation of his answers to questions addressed live as well as other questions submitted by attendees. We hope you will find these responses relevant to your practice.
Q&A Text Module
This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc and Sanofi Genzyme.
In partnership with the Association of Pulmonary Advanced Practice Providers (APAPP).
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose to the audience all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Louie: consulting fees/fees for non-CME/CE services: AstraZeneca, Boehringer Ingelheim, Genentech, GlaxoSmithKline, Regeneron; fees for non-CME/CE services: Sanofi.
© 2021 Practicing Clinicians Exchange. All Rights Reserved. 102221C-QA